Hektas Ticaret T.A.S. (HEKTS.IS)
- Previous Close
3.1900 - Open
3.2000 - Bid 3.2000 x --
- Ask 3.2100 x --
- Day's Range
3.1600 - 3.2400 - 52 Week Range
2.9500 - 16.1800 - Volume
119,864,921 - Avg. Volume
114,884,115 - Market Cap (intraday)
26.892B - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-0.8100 - Earnings Date May 2, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date Dec 2, 2019
- 1y Target Est
4.30
Hektas Ticaret T.A.S. produces, imports, and markets agricultural and veterinary pesticides in Turkey. The company's crop protection products include fungicides, herbicides, insecticides, acaricides, biological insecticides, fumigants and nemathists, plant growth regulators, winter struggle medicines and summer oils, and molluscicide and others. It offers foliar fertilizers, organominerals, drip irrigation, pure fertilizers; and tomato, cotton, and wheat seeds, as well as other plant nutrition products. In addition, the company provides antibacterials, vitamins and minerals, feed additive, analogue, and antiparasite products for animal; environmental health; and pet food and pet care products. The company was incorporated in 1956 and is headquartered in Gebze, Turkey.
hektas.com.tr579
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: HEKTS.IS
View MorePerformance Overview: HEKTS.IS
Trailing total returns as of 5/21/2025, which may include dividends or other distributions. Benchmark is BIST 100 (XU100.IS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: HEKTS.IS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: HEKTS.IS
View MoreValuation Measures
Market Cap
26.89B
Enterprise Value
33.55B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
5.20
Price/Book (mrq)
1.85
Enterprise Value/Revenue
6.49
Enterprise Value/EBITDA
42.66
Financial Highlights
Profitability and Income Statement
Profit Margin
-56.60%
Return on Assets (ttm)
-7.23%
Return on Equity (ttm)
-26.13%
Revenue (ttm)
5.17B
Net Income Avi to Common (ttm)
-2.93B
Diluted EPS (ttm)
-0.8100
Balance Sheet and Cash Flow
Total Cash (mrq)
2.43B
Total Debt/Equity (mrq)
54.16%
Levered Free Cash Flow (ttm)
1.37B